Organigram Global Inc. is focused on producing cannabis for adult recreational consumers. Organigram Global Inc., formerly known as OrganiGram Holdings Inc, is based in TORONTO.
| Revenue (Most Recent Fiscal Year) | $185.07M |
| Net Income (Most Recent Fiscal Year) | $-17.70M |
| PE Ratio (Current Year Earnings Estimate) | 12.27 |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 0.95 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 0.71 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | 1.59% |
| Net Margin (Trailing 12 Months) | 6.03% |
| Return on Equity (Trailing 12 Months) | -15.41% |
| Return on Assets (Trailing 12 Months) | -10.49% |
| Current Ratio (Most Recent Fiscal Quarter) | 2.73 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.32 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | 1.46 |
| Book Value per Share (Most Recent Fiscal Quarter) | $1.86 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.02 |
| Earnings per Share (Most Recent Fiscal Year) | $-0.34 |
| Diluted Earnings per Share (Trailing 12 Months) | $0.14 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Common Shares Outstanding | 136.33M |
| Free Float | 136.21M |
| Market Capitalization | $189.50M |
| Average Volume (Last 20 Days) | 0.74M |
| Beta (Past 60 Months) | 1.51 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 0.09% |
| Percentage Held By Institutions (Latest 13F Reports) | 34.63% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |